Pharmafile Logo

Insights

- PMLiVE

Drug pricing is pharma’s top concern in 2019

More than half of industry respondents say pricing will have the greatest negative impact this year

A unique tool for turning data into brand strategy

Head of Insight Martine Leroy, uses her 25+ years’ experience to develop an exclusive perceptual framework for research design and analysis, which generates a deeper understanding of customer needs and...

Blue Latitude Health

- PMLiVE

Brexit contributes to surge in generic drug prices

Calls for government to protect pharmacies

Navigating the antibiotic resistance crisis

Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Blue Latitude Health

- PMLiVE

FDA clears Sandoz and Pear’s Opioid Use Disorder app

The app incorporates CBT to improve high relapse rates

Someone like you

Patient Influencers are becoming ubiquitous. Should we care?

Generic Differentiation

Even in the cost-led market for generics, differentiated business models evolve

- PMLiVE

Diagnosed Anywhere

What’s wrong? Increasingly, technology-driven tools have the answer

- PMLiVE

Porterhouse celebrates 12 months of smarter insight-driven medical communications

Strategic scientific and medical communications agency, Porterhouse Medical Group, is celebrating the first birthday of Porterhouse Insights, its global research, insight and evidence consultancy.

Porterhouse Medical Group

- PMLiVE

How industry platforms can help transform outcomes-based contracting in healthcare

Could platforms unlock outcomes-based contracting at scale?

- PMLiVE

Medical devices probe uncovers need for “drastic regulatory changes”

Report uncovers lax European regulatory system for medical devices

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links